AronsonJK. What is a clinical trial?Br J Clin Pharmacol2004; 581: 1–3.
2.
SureshK. An overview of randomization techniques: An unbiased assessment of outcome in clinical research. J Hum Reprod Sci2011; 41: 8–11.
3.
De AngelisCDrazenJMFrizelleFA.; International Committee of Medical Journal Editors. Clinical trial registration: A statement from the international committee of medical journal editors. Lancet2004; 364(9438): 911–912.
4.
TurnerLShamseerLAltmanDG. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev2012; 11: MR000030.
5.
TorkildsenOMyhrKMBoL. Disease-modifying treatments for multiple sclerosis – A review of approved medications. Eur J Neurol2016; 23(Suppl. 1): 18–27.
6.
LittleRJRubinDB. Causal effects in clinical and epidemiological studies via potential outcomes: Concepts and analytical approaches. Annu Rev Public Health2000; 21: 121–145.
7.
RubinDB. Using propensity scores to help design observational studies: Application to the tobacco litigation. Health Serv Outcomes Res2001; 23: 169–188.
8.
RosenbaumPR. Design of observational studies. New York: Springer, 2010.
9.
AhmedAAbanIBVaccarinoV. A propensity-matched study of the effect of diabetes on the natural history of heart failure: Variations by sex and age. Heart2007; 93(12): 1584–1590.
10.
NormandSTLandrumMBGuadagnoliE. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: A matched analysis using propensity scores. J Clin Epidemiol2001; 54(4): 387–398.
11.
RosenbaumPR. Observational studies. New York: Springer, 2002.
12.
BaronciniDGhezziAAnnovazziPONatalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis nonresponding to first-line injectable therapies. Mult Scler2016; 22: 1315–1326.
